BioLine RX Ltd ADR buy BiotechBee
Start price
03.09.23
/
50%
€1.97
Target price
31.07.25
€2.50
Performance (%)
18.78%
End price
06.09.23
€2.34
Summary
This prediction ended on 06.09.23 with a price of €2.34. The BUY prediction by BiotechBee finished with a performance of 18.78%. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
BioLine RX Ltd ADR | 16.794% | 16.794% |
iShares Core DAX® | -0.543% | 1.491% |
iShares Nasdaq 100 | -2.696% | -1.235% |
iShares Nikkei 225® | -2.863% | 2.491% |
iShares S&P 500 | -1.105% | 0.013% |
According to BiotechBee what are the pros and cons of BioLine RX Ltd ADR for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread BioLine RX Ltd ADR diskutieren
Buy mit Kursziel 2,5